Noninvasive breast test finds cancer more effectively

SALT LAKE CITY (ABC4 Utah) - An unknown breast test may detect cancer sooner and better than alternative methods.
SALT LAKE CITY (ABC4 Utah) - An unknown breast test may detect cancer sooner and better than alternative methods.

Right now one in nine American women have breast cancer. For that reason, a Utah woman felt a sense of relief when she found out she was cancer free.

"I was fine," said Alesia Carter.  "There was nothing wrong.  Everything came back normal."

Carter is a mom, but she was lactating two years after her daughter was born.

"I was a little concerned," she said.

Then she found out about a revolutionary test called forecyte.

"It was actually a lot easier than I thought it would be," she said.

Forecyte is like a breast pump that sucks discharge out of the breast ducts.  Then, that discharge is scanned for cancer cells.

"This is important because 75 percent of invasive breast cancer comes from the ducts of the breasts," said Dr. John Oglesby.

He is the Director of minimally invasive surgery at Salt Lake Regional Medical Center.  He told ABC4 Utah that forecyte is the most effective way to test for cancer when women have breast abnormalities or discharge.  The procedure is noninvasive and takes only six minutes when compared traditional mammograms, MRIs, ultrasounds, or biopsies.

"Anything we can do to get a diagnosis faster, more effectively, and prevent disease progression is very important," Dr. Oglesby said.

Carter took the test two months ago. Her results were negative.

"Relief," she said.  "It was all relief.  You worry for so long and then you find out everything is fine."

The test is used across the state; however, it's still relatively unknown.  For that reason Carter said, "I think anybody, everybody should know about this test." 

Dr. Oglesby told ABC4 Utah that if women don't have symptoms of a problem, but simply want to get tested because of a family history, there is a more cost effective way.  He recommended a gene test for the BRCA1 or BRCA2 mutation.

Forecyte is supported by most major insurance companies.  If you are uninsured, you should ask your doctor for a possible discount rate.


Page: [[$index + 1]]
comments powered by Disqus
local-businesses.png
cars.png dixie-local.jpg

Popular Stories on Facebook